Delivery Order SPE2DR25D1100-SPE2DR26FEA4F
Award Date 5/20/26
Potential Completion Date 6/11/26
Potential Value $59K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 ml vials, with an ultimate completion date of April 15, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing...
- <p>The Defense Logistics Agency issued a $56,503.48 delivery order to Amerisourcebergen Drug Corp on May 4, 2026, for Ultomiris 300 mg/3 ml vials.</p> <p>The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to military healthcare systems. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of May 26, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $28,251.84 delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for supply of Ultomiris 1,100 mg/11 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 21, 2026. Pricing is firm fixed price. No set-aside applies.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on May 12, 2026, for Ultomiris 300 mg/3 mL vials with a ceiling value of $10,273.36. The order is issued under the DLA Troop Support Medical IDC, a single-award indefinite delivery contract supporting pharmaceutical supply to military healthcare systems globally. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of June 3, 2026.</p>
- <p>The Defense Logistics Agency issued a $25,683.40 delivery order to Amerisourcebergen Drug Corp on April 24, 2026, for 300 milligram/3 milliliter vials of Ultomiris, with ultimate completion by May 15, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under a firm fixed-price structure with no set-aside.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $28,251.74 for the supply of Ultomiris 300 mg/3 mL vials. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, with a ceiling value of $51,366.80 for Ultomiris 300 mg/3 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with an ultimate completion date of March 11, 2026.</p>
- The Defense Logistics Agency awarded a delivery order valued at $10,273.36 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed price contract is scheduled for completion by January 27, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $32,737.85 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. The delivery order was issued on November 10, 2025, as part of the company's broader federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ultomiris (pegtibatase alfa-ires) 1,100 mg/11 ml vials valued at $52,571.70 with a firm fixed price structure. This delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FEA4FDelivery Order
The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on May 20, 2026, for Ultomiris 1,100 mg/11 ml vials. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of June 11, 2026. No set-aside was used. The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to Defense Health Agency and military medical facilities.
Generated 8/18/26, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.1k | 5/19/26 |